INKT
Price:
$12.14
Market Cap:
$60.48M
MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in immune system dysfunction. The company's leading investigational therapy is AGENT-797. This product is an allogeneic, ready-to-use iNKT cell therapy, presently in Phase 1 clinical studies to assess its effectiveness against different forms of myeloma. Established in 2017, the company was previously known ...[Read more]
Industry
Biotechnology
IPO Date
2021-10-15
Stock Exchange
NASDAQ
Ticker
INKT
According to MiNK Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.34. This represents a change of 3.25% compared to the average of -4.20 of the last 4 quarters.
The mean historical PE Ratio of MiNK Therapeutics, Inc. over the last ten years is -7.96. The current -4.34 PE Ratio has changed 5.35% with respect to the historical average. Over the past ten years (40 quarters), INKT's PE Ratio was at its highest in in the March 2023 quarter at 0.10. The PE Ratio was at its lowest in in the December 2020 quarter at -55.45.
Average
-7.96
Median
-3.81
Minimum
-24.44
Maximum
-1.64
Discovering the peaks and valleys of MiNK Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 58.86%
Maximum Annual PE Ratio = -1.64
Minimum Annual Increase = -79.79%
Minimum Annual PE Ratio = -24.44
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.81 | 58.33% |
| 2024 | -2.40 | 46.90% |
| 2023 | -1.64 | -47.91% |
| 2022 | -3.14 | -36.41% |
| 2021 | -4.94 | -79.79% |
| 2020 | -24.44 | 58.86% |
The current PE Ratio of MiNK Therapeutics, Inc. (INKT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.61
5-year avg
-3.18
10-year avg
-7.96
MiNK Therapeutics, Inc.’s PE Ratio is less than OS Therapies Incorporated (-1.80), less than vTv Therapeutics Inc. (1.75K), less than IO Biotech, Inc. (-0.01), less than Werewolf Therapeutics, Inc. (-0.29), less than Spruce Biosciences, Inc. (-1.39), less than Outlook Therapeutics, Inc. (-1.16), less than CervoMed Inc. (-1.30), less than Gain Therapeutics, Inc. (-3.24), less than NRx Pharmaceuticals, Inc. (-3.09), greater than Equillium, Inc. (-8.11),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.80 | $85.96M | |
| 1.75K | $91.71M | |
| -0.01 | $885.69K | |
| -0.29 | $17.07M | |
| -1.39 | $71.84M | |
| -1.16 | $65.00M | |
| -1.30 | $39.26M | |
| -3.24 | $80.19M | |
| -3.09 | $68.62M | |
| -8.11 | $108.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MiNK Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MiNK Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MiNK Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for MiNK Therapeutics, Inc. (INKT)?
What is the highest PE Ratio for MiNK Therapeutics, Inc. (INKT)?
What is the 3-year average PE Ratio for MiNK Therapeutics, Inc. (INKT)?
What is the 5-year average PE Ratio for MiNK Therapeutics, Inc. (INKT)?
How does the current PE Ratio for MiNK Therapeutics, Inc. (INKT) compare to its historical average?